dl-Grepafloxacin HCl (CAS 119914-60-2 (free base))

dl-Grepafloxacin HCl, a racemic mixture of the levo and dextro isomers, is a broad-spectrum antibacterial agent primarily utilized in microbiological research to study bacterial resistance mechanisms and the efficacy of quinolone compounds in inhibiting bacterial growth. This compound operates by targeting and inhibiting DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication and cell division. The inhibition process disrupts the supercoiling mechanism of bacterial DNA, which is essential for the transcription and replication processes, thereby impeding bacterial cell proliferation. dl-Grepafloxacin HCl′s ability to interfere with these fundamental bacterial processes makes it useful in the exploration of bacterial genetics and the development of new antibacterial strategies. Its use in varied experimental setups helps in elucidating the dynamics of bacterial adaptation to antimicrobial pressures and can aid in the screening for novel antibacterial agents.